Events
Past Event
BME Michael Jaharis Lecture 2026: Dr. Omid Veiseh
McCormick - Biomedical Engineering Department (BME)
4:00 PM
//
L211, Technological Institute
Details
Please join us for the annual BME Jaharis Lecture.
Dr. Omid Veiseh from Rice University presents "Bioengineering Cell-based Therapeutics"
Abstract: Cell-based therapeutics are an emerging modality that can potentially treat many currently intractable diseases through uniquely powerful modes of action. Our group is innovating new biomaterials and cellular constructs for medicine and biology by combining chemical biology, cellular engineering, and multi-scale fabrication. We have pioneered innovative approaches to synthesizing and in vivo screening of large libraries of biomaterial formulations for tailored applications in immunology and medicine. In my talk, I will describe our advances in discovering immunomodulatory biomaterials that can interact appropriately with the host immune system for localized immunomodulation. I will highlight our efforts to develop “cytokine factories” locally activating the innate and adaptive immune response to generate systemic immunotherapy and eradicate metastatic cancer. This approach has advanced to phase I/II human clinical trials for treating recurrent, refractory ovarian cancer.
Bio: Dr. Omid Veiseh, Ph.D., is a Professor and CPRIT Scholar in Cancer Research in the Departments of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He is also the Director of Rice University's Biotech Launch Pad, a new initiative with a mission to accelerate the translation of Rice University discoveries and technologies into clinical practice to provide rapid patient access to leading-edge therapeutic products. He leads an interdisciplinary translational research program to engineer and commercialize next-generation cell-based therapeutics for various human diseases. His team leverages the latest techniques in synthetic biology, immunoengineering, and materials science to develop innovative cell-based platforms for real-time and feedback-regulated production of biologics. Throughout his career, he has authored or co-authored more than 80 peer-reviewed publications, including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and Nature Biomedical Engineering. He is an inventor on more than 50 pending or awarded patents. He is also a serial entrepreneur who has co-founded multiple biotechnology companies, collectively attracting ~ $500M in private and public investment capital. Dr. Veiseh has been elected as a fellow of the Controlled Release Society and a member of the National Academy of Inventors.
Time
Thursday, April 16, 2026 at 4:00 PM - 5:00 PM
Location
L211, Technological Institute Map
Contact
Calendar
McCormick - Biomedical Engineering Department (BME)
BME Seminar Series - Dr Cindy Reinhart-King
McCormick - Biomedical Engineering Department (BME)
4:00 PM
//
L211, Technological Institute
Details
Mechanometabolic Control of Cell Behavior
Abstract
To move, cells must utilize ATP to fuel the cellular contractility and forces that sustain migration, however very little is known about how the metabolic state of a cell affects its ability to migrate and vice versa. In this talk, I will describe my lab’s efforts to understand the forces driving cell movements in the tumor microenvironment and the energy required for movement. Combining tissue engineering approaches, mouse models, and patient samples, we create and validate in vitro systems to understand how cells navigate the tumor stroma environment to identify novel targets of cancer metastasis. Microfabrication and native biomaterials are used to build mimics of the paths created and taken by cells during metastasis. Using these platforms, we have described a role for a balance between cellular energetics, cell and matrix stiffness, and confinement in determining migration behavior. Moreover, we have extended this work into investigating the intersection of diabetes and the diabetic tissue microenvironment with tumor progression, showing that mechanical changes in the tissue due to diabetes can promote cancer. Overall, our work has demonstrated key mechanical drivers of metastasis within the tissue microenvironment.
Bio
Cynthia Reinhart-King is the John W. Cox Professor and Department Chair in the Department of Bioengineering at Rice University. Before joining Rice, she was a University Distinguished Professor in Biomedical Engineering and Cell and Developmental Biology at Vanderbilt University, where she also served as Senior Associate Dean for Research in the School of Engineering. She obtained undergraduate degrees in Chemical Engineering and Biology at MIT and her PhD at the University of Pennsylvania in the Department of Bioengineering. Her lab’s research interests are cell and tissue mechanobiology in cancer and atherosclerosis. She was awarded the Rita Schaffer Young Investigator Award, the inaugural Mid-Career Award, and the Herb Voigt Service Award from the Biomedical Engineering Society, an NSF CAREER Award, the Sonny Yau ‘72 Excellence in Teaching Award, the Cornell University Cook Award and the Zellman Warhaft Award from the Cornell College of Engineering, the Vanderbilt Chancellor’s Award for Research and the Edward J. White Service Award from the Vanderbilt University School of Engineering. She is a fellow of the Biomedical Engineering Society, the American Institute for Medical and Biological Engineering (AIMBE), and the International Academy of Medical and Biological Engineering, and she was an inaugural New Voices Fellow of the National Academies of Science, Engineering and Medicine. She served as a standing member of the NIH CMT study section panel, an elected Board Member of AIMBE, Secretary and Elected Board member of BMES, and Chair of the Diversity and Inclusion Committee of AIMBE. She is the current Past-President of the Biomedical Engineering Society.
Time
Thursday, May 7, 2026 at 4:00 PM - 5:00 PM
Location
L211, Technological Institute Map
Contact
Calendar
McCormick - Biomedical Engineering Department (BME)